Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other financing activities (2021 - 2025)

Historic Other financing activities for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $63500.0.

  • HCW Biologics' Other financing activities changed N/A to $63500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $638045.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Other financing activities is $63500.0.
  • Over the past 5 years, HCW Biologics' Other financing activities peaked at $824312.0 during Q2 2021, and registered a low of -$924312.0 during Q3 2021.
  • For the 4-year period, HCW Biologics' Other financing activities averaged around $190776.8, with its median value being $100000.0 (2021).
  • The largest annual percentage gain for HCW Biologics' Other financing activities in the last 5 years was 11567.33% (2022), contrasted with its biggest fall of 11567.33% (2022).
  • Quarter analysis of 4 years shows HCW Biologics' Other financing activities stood at -$924312.0 in 2021, then surged by 104.94% to $45677.0 in 2022, then surged by 1296.86% to $638045.0 in 2024, then crashed by 90.05% to $63500.0 in 2025.
  • Its Other financing activities stands at $63500.0 for Q3 2025, versus $802602.0 for Q2 2025 and $22297.0 for Q1 2025.